Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAOI-B (Sodium Benzoate) for Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT01600469Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jan 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium benzoate in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by Chang Gung Memorial Hospital. Started Jan 2012; status: completed.
02
Drugs
sodium benzoate
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01600469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01600469.